(Q40800058)

23 September 2017

Pathophysiological Role of Growth Factors in Diabetic Kidney Disease: Focus on Innovative Therapy (English)

1 reference

23 September 2017

1 reference

1

Flyvbjerg A

1 reference

23 September 2017

Hill C

2

1 reference

PubMed ID

10461173

23 September 2017

Logan A

series ordinal

3

1 reference

23 September 2017

1 September 1999

1 reference

Trends in Endocrinology and Metabolism

23 September 2017

1 reference

23 September 2017

10

1 reference

23 September 2017

267-272

1 reference

23 September 2017

7

1 reference

Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the kidney of the chronically hypoinsulinemic rat and hyperinsulinemic rat

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Albumin excretion rate, serum insulin-like growth factor-I and glomerular filtration rate in type I diabetes mellitus at puberty

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Effect of long-acting somatostatin analog (Somatulin) on renal hyperfiltration in patients with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900167-8

7 January 2021

A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1210/ENDO.137.11.8895392

Identifiers

DOI

10.1016/S1043-2760(99)00167-8

1 reference

23 September 2017

1 reference

PubMed ID

10461173